Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Marie Wong, Chelsea Mayoh, Loretta M. S. Lau, et al.
Nature Medicine (2020) Vol. 26, Iss. 11, pp. 1742-1753
Closed Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
Kandamurugu Manickam, Monica R. McClain, Laurie Demmer, et al.
Genetics in Medicine (2021) Vol. 23, Iss. 11, pp. 2029-2037
Open Access | Times Cited: 408
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Cornelis M. van Tilburg, Elke Pfaff, Kristian W. Pajtler, et al.
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2764-2779
Open Access | Times Cited: 191
A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 141
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies
Pablo Berlanga, Gaëlle Pierron, Ludovic Lacroix, et al.
Cancer Discovery (2022) Vol. 12, Iss. 5, pp. 1266-1281
Open Access | Times Cited: 124
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
Elise Fiala, Gowtham Jayakumaran, Audrey Mauguen, et al.
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 357-365
Open Access | Times Cited: 123
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Joo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2487-2502.e13
Open Access | Times Cited: 112
Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial
D. Williams Parsons, Katherine A. Janeway, David R. Patton, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 20, pp. 2224-2234
Open Access | Times Cited: 95
Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme
Alona Sosinsky, John C. Ambrose, William Cross, et al.
Nature Medicine (2024) Vol. 30, Iss. 1, pp. 279-289
Open Access | Times Cited: 87
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
Anita Villani, Scott Davidson, Nisha Kanwar, et al.
Nature Cancer (2022) Vol. 4, Iss. 2, pp. 203-221
Open Access | Times Cited: 78
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors
Sanju Sinha, Rahulsimham Vegesna, Sumit Mukherjee, et al.
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 938-952
Open Access | Times Cited: 31
Precision-guided treatment in high-risk pediatric cancers
Loretta M. S. Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh, et al.
Nature Medicine (2024) Vol. 30, Iss. 7, pp. 1913-1922
Open Access | Times Cited: 24
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers
Arlet Acanda de la Rocha, Noah Berlow, Maggie Fader, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 990-1000
Open Access | Times Cited: 23
Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing
Scott Newman, Joy Nakitandwe, Chimene Kesserwan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 12, pp. 3008-3027
Open Access | Times Cited: 84
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies
Izac J. Findlay, Geoffry N. De Iuliis, Ryan J. Duchatel, et al.
Oncogene (2021) Vol. 41, Iss. 4, pp. 461-475
Open Access | Times Cited: 61
Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers
Neerav Shukla, Max F. Levine, Gunes Gundem, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Implementation of Whole-Genome and Transcriptome Sequencing Into Clinical Cancer Care
Edwin Cuppen, Olivier Elemento, Richard Rosenquist, et al.
JCO Precision Oncology (2022), Iss. 6
Open Access | Times Cited: 54
JAFFAL: detecting fusion genes with long-read transcriptome sequencing
N. Davidson, Ying Chen, Teresa Sadras, et al.
Genome biology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 47
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
Arne Jahn, Andreas Rump, Thomas J. Widmann, et al.
Annals of Oncology (2022) Vol. 33, Iss. 11, pp. 1186-1199
Open Access | Times Cited: 47
ACCELERATE – Five years accelerating cancer drug development for children and adolescents
Andrew D.J. Pearson, Susan Weiner, Peter C. Adamson, et al.
European Journal of Cancer (2022) Vol. 166, pp. 145-164
Open Access | Times Cited: 40
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer
Alanna J. Church, Laura Corson, Pei‐Chi Kao, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1581-1589
Closed Access | Times Cited: 40
Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology
Virgile Raufaste-Cazavieille, Raoul Santiago, Arnaud Droit
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 39
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Sun, Paul Daniel, Gabrielle Bradshaw, et al.
Cancer Cell (2023) Vol. 41, Iss. 4, pp. 660-677.e7
Open Access | Times Cited: 37
Implementation of precision medicine in healthcare—A European perspective
Albrecht Stenzinger, Ejner K. Moltzen, Eva C. Winkler, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 4, pp. 437-454
Open Access | Times Cited: 36
The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer
Joseph Flores‐Toro, Subhashini Jagu, Gregory T. Armstrong, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 24, pp. 4045-4053
Open Access | Times Cited: 32
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
Chelsea Mayoh, Jie Mao, Jinhan Xie, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2716-2732
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top